Power-Pak C.E. is pleased to present a complimentary CE WEBINAR
Lisa M. Holle, PharmD, BCOP, FISOPP
Associate Clinical Professor
UConn School of Pharmacy
Department of Pharmacy Practice
Storrs, CT
Clinical Pharmacy Specialist
UConn Health Carole and Ray Neag Comprehensive Cancer Center
Farmington, CT
Andrea Moran, MSN, APRN-BC
Lead Oncology Nurse Practitioner
UConn Health Carole and Ray Neag Comprehensive Cancer Center
Farmington, CT
Wednesday, September 23, 2020
3:00 – 4:30 PM ET US

Thursday, October 1, 2020
1:00 – 2:30 PM ET US
To provide oncology nurses, nurse practitioners, and pharmacists with advanced and up-to-date knowledge of immune checkpoint inhibitors alone or in combination with other agents for the treatment of cancer, enhance their confidence and competence in identifying and recommending appropriate patient-specific treatments and developing optimal toxicity prevention and management strategies, thus leading to improved patient outcomes during the COVID-19 pandemic and beyond.
Learning Objectives
Upon completion of this activity, participants should be better able to:

Discuss the current and emerging use of immune checkpoint inhibitors (ICIs) and ICI combination regimens for the treatment of cancer

Demonstrate interventions to effectively prevent or manage toxicities of ICIs and ICI combination therapies

Distinguish best practices for managing patients on ICIs during the coronavirus disease 2019 pandemic

Develop an interprofessional practice model aimed to improve outcomes in patients receiving ICIs

Credits: 1.5 hour (0.15 ceu)
Duration: 90 minutes
Location: From the convenience of your home or business; accessible via both PC and MAC
Fee: There is no fee for this educational activity
Target Audience: Oncology nurses, nurse practitioners, and pharmacists working with COVID-19 patients
Type of Activity: Application


Introduction (5 minutes)
Presentation (75 minutes)
Conclusions & Question & Answer Session (10 minutes)
How to Earn Credit
Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live webinar; and 3) complete the evaluation form directly after the event with a maximum of within 60 days of attending the live session. To answer the questions, click on your selected choice for each answer then proceed to the next question. Your credit will automatically uploaded to CPE Monitor.
Required Computer Hardware/Software
Please ensure the computer system you plan to use meets the following minimum requirements:

Operating System: Windows 98 or higher & Macintosh 2.2 or higher

Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher

Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible

Peripherals: Computer speakers or headphones

Monitor Screen Resolution: 320 x 480 or higher

Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Postgraduate Healthcare Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy: Postgraduate Healthcare Education, LLC (PHE) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
UAN: 0430-0000-20-107-L01-P
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated for 0.7 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Jointly provided by Postgraduate Institute for Medicine and Postgraduate Healthcare Education. This activity is supported by independent educational grants from Bristol-Myers Squibb and Merck & Company.